What Is Black Diamond Therapeutics, Inc (BDTX) Worth in 2026?
According to the CirclFi Deep Alpha Valuation Engine, our multi-model framework produces a cautiously optimistic read on Black Diamond Therapeutics, Inc at $1.90. With an estimated intrinsic value of $2.76 and 7 of 11 models pointing higher, the average implied return is +45.1%. The most optimistic model, EROIC, places fair value at $5.45 (+187.0%), while ML-RIV — the most conservative — estimates $0.62 (-67.3%). This +254.3% gap reflects genuine analytical uncertainty about Black Diamond Therapeutics, Inc's intrinsic worth.
What Do the Models Say About BDTX?
11 of 13 models are currently active for BDTX. Of these, 8 models suggest upside while 3 models suggest overvaluation. The Bayesian DCF estimates BDTX's intrinsic value at $0.65, implying -65.6% downside from the current price. See which stocks rank higher →
How Does BDTX Rank in Biological Products, (No Diagnostic Substances)?
Among 139 Biological Products, (No Diagnostic Substances) stocks, BDTX ranks #58 by Quality of Company score. CirclFi's QOC score of 5.6/10 evaluates 32 fundamental signals. A score of 5.6 reflects mixed fundamentals.
See all Most Undervalued Biological Products, (No Diagnostic Substances) Stocks →
Black Diamond Therapeutics, Inc operates in a competitive landscape where fundamental quality metrics are key differentiators for long-term value creation.
Is BDTX a Value Trap?
CirclFi's Value Trap algorithm assigns BDTX a score of 30/100 (LOW). This indicates low risk. The financial profile does not exhibit typical value trap warning signs. The score cross-references apparent undervaluation against fundamental deterioration signals. Browse lowest value-trap stocks →
Multi-Model Methodology
11 of 13 models are active for Black Diamond Therapeutics, Inc. Broad coverage provides high confidence. Each model applies a fundamentally different valuation philosophy. See the complete methodology →
According to the CirclFi Deep Alpha Valuation Engine, Black Diamond Therapeutics, Inc scores 5.6 out of 10 on our 32-signal quality assessment, a solid rating that maintains reasonable quality metrics with some areas for improvement. The QOC score synthesizes profitability margins, revenue growth reliability, debt management, and capital allocation into a single metric designed to separate durable businesses from statistically cheap ones.
The gap between the most bullish and bearish model spans +254.3% — demonstrating why single-model analysis is dangerous. Browse all stocks with 13-model coverage →
Data Sources & Confidence
Every BDTX valuation is built from SEC EDGAR XBRL filings — 700+ standardized financial tags. Macroeconomic context from FRED calibrates discount rates, while GDELT news sentiment feeds into our Sentiment SOTP model. All pipelines run daily. Read the complete data methodology →
Across BDTX's 11 active models, average confidence is 28%. Lower confidence may reflect limited history or high volatility.
CirclFi's output is a research starting point, not a buy/sell signal. All data updates daily. Read the full methodology →
Buy with Gumroad